Advanced search
Publication Cover
Current Medical Research and Opinion Volume 39, 2023 - Issue 11
Submit an article Journal homepage
1,149
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Health-related quality of life outcomes associated with zanubrutinib versus ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: results from the ALPINE Trial

Constantine S. Tama Alfred Health and Monash University, Melbourne, AustraliaView further author information
,
Nicole Lamannab Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USAView further author information
,
Susan M. O'Brienc Chao Family Comprehensive Cancer Center, University of California, Irvine, CA, USAView further author information
,
Lugui Qiud State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, ChinaView further author information
,
Keri Yange BeiGene USA, Inc, San Mateo, CA, USAView further author information
,
Gisoo Barnese BeiGene USA, Inc, San Mateo, CA, USAView further author information
,
Ken Wue BeiGene USA, Inc, San Mateo, CA, USAView further author information
,
Tommi Salmif BeiGene Switzerland GmbH, Basel, SwitzerlandView further author information
&
Jennifer R. Browng Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2040-4961View further author information
ORCID Icon show all
Pages 1497-1503 | Received 27 Jul 2023, Accepted 20 Sep 2023, Published online: 27 Oct 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.